Streetbeat News

Stock Prices

NBIX

Neurocrine Biosciences (NASDAQ:NBIX) has received varied analyst ratings over the past three months, with a general trend towards bullishness. Analysts have set a 12-month average price target of $174.87, reflecting a 5.85% increase from the previous target. The company has shown strong financial performance with a 30.37% revenue growth rate, a net margin of 11.01%, and a prudent debt management strategy.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:01 pm

EQH

Equitable Holdings (NYSE:EQH) has been analyzed by 9 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target is $47.0, up 9.3% from the previous target. Recent analyst actions include both raises and lowers in ratings and price targets. Equitable Holdings has shown strong financial performance with significant revenue growth and high ROE, but also has a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm

VOYA

In the past three months, 11 analysts have provided ratings for Voya Financial (NYSE:VOYA), with a mix of bullish and indifferent sentiments. The average 12-month price target is $82.45, slightly up from the previous $81.91. Analysts have adjusted their ratings and price targets, reflecting their views on Voya's market position and financial performance. Voya Financial has shown strong financial health with a net margin of 10.1% and a return on equity of 4.9%, although its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm

FRT

Federal Realty Investment (NYSE:FRT) has been analyzed by six analysts, showing a range of perspectives from bullish to bearish. Recent analyst actions include raised price targets, with an average target of $118.5, reflecting a 7.89% increase from the previous average. The company shows strong financial metrics, including a net margin of 37.15% and a revenue growth rate of 5.48%.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm

HOLX

Hologic (NASDAQ:HOLX) has outperformed the market over the past 10 years with an average annual return of 12.59%, surpassing the market by 1.79% annually. A $1000 investment in HOLX 10 years ago would now be worth $3,280.24.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm

RBC

RBC Bearings (NYSE:RBC) has significantly outperformed the market over the past 15 years, with an annualized return of 18.61%. A $100 investment 15 years ago would now be worth $1,318.07, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm

XRPUSD

XRP's price has risen by 5.45% in the last 24 hours, continuing a positive trend with a 6% gain over the past week. Despite the price increase, trading volume has decreased by 18% over the week. XRP's market cap is ranked #7 at $33.82 billion.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 7:00 pm

LAES

SEALSQ shares are experiencing an upward trend following the announcement of their new QS7001 chip.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 6:46 pm

VZ

Financial giants have shown a bearish sentiment towards Verizon Communications (NYSE:VZ) with 75% of options trades being bearish. The stock is currently priced at $40.81, with analysts providing mixed ratings and target prices ranging from $42 to $51.

Portfolio Pulse from Benzinga Insights

August 19, 2024 | 6:45 pm

OS

Analysts have initiated coverage on OneStream, Inc. (NASDAQ:OS) with positive ratings and price targets ranging from $30 to $35. The company, which recently started trading, is noted for its innovative AI integration and strong market growth potential. Analysts highlight its high retention rate, rapid revenue growth, and potential to capture significant market share in the business performance management software sector.

Portfolio Pulse from Anusuya Lahiri

August 19, 2024 | 6:42 pm